Recently studies demonstrated that PRPS2 was involved in cancer cell proliferation and metastasis of neuroblastoma malignancy, which was regulated by both MYCN and activating enhancer binding protein-4 (TFAP4) 19. The gene discussed is TFAP4; the disease is cancer.